| {"0": "Pathogenic escherichia coli infection", "1": "Parkinubiquitin proteasomal system pathway", "2": "Alzheimers disease", "3": "Alzheimers disease and mirna effects", "4": "Electron transport chain oxphos system in mitochondria", "5": "Mitochondrial complex iv assembly", "6": "Sphingolipid metabolism integrated pathway", "7": "Sphingolipid metabolism in senescence", "8": "Sphingolipid metabolism overview", "9": "Ferroptosis", "10": "Sphingolipid pathway", "11": "Metapathway biotransformation phase i and ii", "12": "Nonalcoholic fatty liver disease", "13": "Cholesterol metabolism with bloch and kandutschrussell pathways", "14": "Glycosylation and related congenital defects", "15": "Genes related to primary cilium development based on crispr", "16": "Amyotrophic lateral sclerosis als", "17": "Ppar signaling pathway", "18": "Nrf2 pathway", "19": "Mitochondrial complex i assembly model oxphos system", "20": "Ciliopathies", "21": "Onecarbon metabolism and related pathways", "22": "Apoptosis modulation and signaling", "23": "Oxidative phosphorylation", "24": "Spinal cord injury", "25": "Nuclear receptors metapathway", "26": "Epo receptor signaling", "27": "Envelope proteins and their potential roles in edmd physiopathology", "28": "Physiological and pathological hypertrophy of the heart", "29": "Allograft rejection", "30": "Vasopressinregulated water reabsorption", "31": "Pdgfrbeta pathway", "32": "Factors and pathways affecting insulinlike growth factor igf1akt signaling", "33": "Hepatitis b infection", "34": "4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression", "35": "Micrornas in cardiomyocyte hypertrophy", "36": "Serotonin htr1 group and fos pathway", "37": "Physicochemical features and toxicityassociated pathways", "38": "G1 to s cell cycle control"} |